Based on the AVEROSS trial, apixaban was superior to aspirin in patients unsuitable for warfarin in stroke prevention in nonvalvular AF. There is a need to reconsider the benefits of using aspirin ...

Vitamin K-inhibiting anticoagulants, especially warfarin, have become standard treatment for reducing the incidence of strokes and systemic emboli in patients with nonvalvular atrial fibrillation ...

Data from a Japanese registry may be useful for characterizing frailty among older patients with nonvalvular atrial fibrillation (NVAF), possibly opening the door to better treatment decisions and ...